Assessment of extent of breast cancer: Comparison between digital breast tomosynthesis and full-field digital mammography

Mun, Han Song; Kim, H.H.; Shin, Hee Jung; Cha, Jae-Ryong; Ruppel, Patricia; Oh, Hongmin; Chae, Eun Young

doi:10.1016/j.crad.2013.07.006

Cited by 50 publications

(35 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[3][4][5] DBT has also been found to be superior to FFDM in measuring tumour size 15,16 and is at least comparable with supplementary views in the assessment of non-calcified lesions. [9][10][11] The tumour outline can be seen in more cases on DBT as compared with FFDM, which makes local staging of tumours significantly more accurate with DBT.…”

Section: Resultsmentioning

confidence: 99%

Digital breast tomosynthesis at screening assessment: are two views always necessary?

Haq¹,

Lim²,

Maxwell³

et al. 2015

BJR

View full text Add to dashboard Cite

Objective: The current recommendation from the UK National Health Service Breast Screening Programme is that digital breast tomosynthesis (DBT) can be used for further assessment of possible screen-detected softtissue abnormalities in place of spot compression views and when used should be performed in two projections. The aim of the study was to assess whether twoview DBT is necessary if the abnormality is seen only in one view on initial full-field digital mammography (FFDM). Methods: 617 cases with possible masses, distortions and asymmetrical densities visualized only in one view on screening FFDM were included. All of these females underwent two-view DBT, clinical examination and ultrasound. The FFDM and DBT findings on each view were compared and correlated with the histological diagnosis.

show abstract

Section: Resultsmentioning

confidence: 99%

Digital breast tomosynthesis at screening assessment: are two views always necessary?

Haq¹,

Lim²,

Maxwell³

et al. 2015

BJR

View full text Add to dashboard Cite

show abstract

“…Tumor size of 73 cancers measured by using MLO-view DBT exhibited higher correlation with pathologic findings than FFDM, and was similar to US (129). Applying a criterion of 61 cm as threshold for concordance in tumor size with pathologic findings in 173 tumors, Mun et al (130) reported that DBT was more concordant than FFDM. Applying 6 5 mm as threshold for concordance with pathologic findings, Luparia et al (131) reported that the concordance and correlation from a study of 149 cancers was highest for MR imaging, followed by DBT, and was better than FFDM and US.…”

Section: Dbt In Clinical Managementmentioning

confidence: 96%

Digital Breast Tomosynthesis: State of the Art

et al. 2015

View full text Add to dashboard Cite

This topical review on digital breast tomosynthesis (DBT) is provided with the intent of describing the state of the art in terms of technology, results from recent clinical studies, advanced applications, and ongoing efforts to develop multimodality imaging systems that include DBT. Particular emphasis is placed on clinical studies. The observations of increase in cancer detection rates, particularly for invasive cancers, and the reduction in false-positive rates with DBT in prospective trials indicate its benefit for breast cancer screening. Retrospective multireader multicase studies show either noninferiority or superiority of DBT compared with mammography. Methods to curtail radiation dose are of importance

show abstract

“…[28][29][30] Improved lesion visibility, size and classification compared with standard film or digital mammography have been reported [31][32][33][34][35][36][37][38] and the possibility that DBT could reduce the need for additional mammographic views at least for non-calcified lesions [39][40][41][42] has been suggested. There are mixed reports of the sensitivity of DBT for the detection of microcalcifications 32,[43][44][45][46][47][48][49][50][51] that may be partly as a result of the different techniques used for image reconstruction and the need to combine image slices into thicker slabs for optimal visualisation of microcalcification clusters.…”

Section: Diagnostic Accuracymentioning

confidence: 99%

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme – a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone

Gilbert

Tucker

Gillan

et al. 2015

Health Technology Assessment

155

View full text Add to dashboard Cite

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme -a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE) (www.publicationethics.org/).Editorial contact: nihredit@southampton.ac.ukThe full HTA archive is freely available to view online at www.journalslibrary.nihr.ac.uk/hta. Print-on-demand copies can be purchased from the report pages of the NIHR Journals Library website: www.journalslibrary.nihr.ac.uk Criteria for inclusion in the Health Technology Assessment journalReports are published in Health Technology Assessment (HTA) if (1) they have resulted from work for the HTA programme, and (2) they are of a sufficiently high scientific quality as assessed by the reviewers and editors.Reviews in Health Technology Assessment are termed 'systematic' when the account of the search appraisal and synthesis methods (to minimise biases and random errors) would, in theory, permit the replication of the review by others. HTA programmeThe HTA programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care.The journal is indexed in NHS Evidence via its abstracts included in MEDLINE and its Technology Assessment Reports inform National Institute for Health and Care Excellence (NICE) guidance. HTA research is also an important source of evidence for National Screening Committee (NSC) policy decisions.For more information about the HTA programme please visit the website: http://www.nets.nihr.ac.uk/programmes/hta This reportThe research reported in this issue of the journal was funded by the HTA programme as project number 09/22/182. The contractual start date was in December 2010. The draft report began editorial review in February 2014 and was accepted for publication in August 2014. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors' report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report. Background: Digital breast tomosynthesis (DBT) is a three-dimensional mammography technique with the potential to improve accuracy by improving differentiation between malignant and non-malignant lesions.

show abstract

Assessment of extent of breast cancer: Comparison between digital breast tomosynthesis and full-field digital mammography

Cited by 50 publications

References 16 publications

Digital breast tomosynthesis at screening assessment: are two views always necessary?

Digital breast tomosynthesis at screening assessment: are two views always necessary?

Digital Breast Tomosynthesis: State of the Art

The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme – a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone

Contact Info

Product

Resources

About